Related Experiment Video
Updated: May 10, 2026
08:16
An IL-8 Transiently Transgenized Mouse Model for the In Vivo Long-term Monitoring of Inflammatory Responses
Published on: July 7, 2017
Interleukin 8 and acute lung injury
Timothy Craig Allen1, Anna Kurdowska
1From the Departments of Pathology (Dr Allen) and Biochemistry (Dr Kurdowska), University of Texas Health Science Center at Tyler. Dr Allen is now located at the University of Texas Medical Branch at Galveston, Texas.
Archives of Pathology & Laboratory Medicine
|June 21, 2013
Summary
Interleukin 8 (IL-8) and its autoantibody complexes contribute to acute lung injury and acute respiratory distress syndrome by activating neutrophils. Targeting these interactions may lead to new therapies for acute lung injury.
Area of Science:
- Pulmonary Medicine
- Immunology
- Cell Biology
Background:
- Acute lung injury (ALI) is a critical syndrome characterized by inflammation and vascular damage, often leading to acute respiratory distress syndrome (ARDS).
- Neutrophils and Interleukin 8 (IL-8) are key mediators in the pathogenesis of ALI.
- The role of autoantibodies against IL-8 and their interaction with FcγRIIa receptors in ALI development requires further elucidation.
Purpose of the Study:
- To investigate the role of Interleukin 8 (IL-8) and anti-IL-8 autoantibody:IL-8 complexes in the pathogenesis of acute lung injury (ALI).
- To explore the interaction between these complexes and FcγRIIa receptors in the context of ALI and acute respiratory distress syndrome (ARDS).
Main Methods:
- The study focuses on the molecular mechanisms involving neutrophils, IL-8, anti-IL-8 autoantibody:IL-8 complexes, and FcγRIIa receptors in ALI.
- Investigates the potential impact of these complexes on neutrophil apoptosis and lung endothelial cells in ARDS.
Main Results:
- IL-8, a potent neutrophil activator, forms complexes with anti-IL-8 autoantibodies.
- These complexes interact with FcγRIIa receptors, contributing to ALI development, potentially through effects on neutrophil apoptosis.
- Complexes may also interact with lung endothelial cells in ARDS patients.
Conclusions:
- IL-8 and its autoantibody complexes are implicated in the pathogenesis of ALI and ARDS.
- Targeting neutrophil activation pathways involving IL-8 and FcγRIIa receptors presents a potential therapeutic strategy.
- Further research may yield molecular therapies to reduce ARDS mortality and prevent ALI.
Related Concept Videos
01:26Acute Inflammation I: Cellular Phase
The cellular phase of acute inflammation is a tightly orchestrated sequence of events that recruits leukocytes, primarily neutrophils, to sites of tissue injury or infection. Following the initial vascular changes, this phase ensures effective immune cell migration, activation, and function at the affected site to eliminate pathogens and initiate tissue repair.Leukocyte Recruitment CascadeLeukocyte recruitment happens in four steps: margination, adhesion, transmigration, and chemotaxis. Reduced...
01:25Acute Inflammation II: Local and Systemic Effects
Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...
01:21Acute Respiratory Failure-II
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
01:29Acute Respiratory Failure-V
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
01:29Pneumonia I: Introduction
Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...